| 发明名称 | High dose extended-release potassium citrate wax matrix tablet | ||
| 摘要 | The present invention relates to a high dose extended-release potassium citrate tablet containing carnauba wax, which contains a first portion of melt- or heat-granulated carnauba wax and potassium citrate; and a second portion of non-granulated potassium citrate. The high dose extended-release potassium citrate tablet of this invention has robust batch-to-batch dissolution and friability; and leads to improved production capacity and reduced production cost. | ||
| 申请公布号 | US9295659(B2) | 申请公布日期 | 2016.03.29 |
| 申请号 | US201314431374 | 申请日期 | 2013.02.28 |
| 申请人 | UNITED LABORATORIES, INC. | 发明人 | Mendoza Wendell G.;Santos Rita Josefina M.;Dee Kennie U. |
| 分类号 | A61K9/16;A61K31/194;A61K9/20 | 主分类号 | A61K9/16 |
| 代理机构 | Banner & Witcoff, Ltd. | 代理人 | Banner & Witcoff, Ltd. |
| 主权项 | 1. A high dose extended-release potassium citrate tablet containing carnauba wax, which comprises: a first portion of melt- or heat-granulated potassium citrate and carnauba wax; and a second portion of non-granulated potassium citrate. | ||
| 地址 | Mandaluyong PH | ||